Nalaganje...
Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance
Oxaliplatin is a third-generation platinum compound that has shown a wide range of anti-tumour activity in metastatic cancer and in multiple cell lines. It contains a diaminocyclohexane carrier ligand and is one of the least toxic platinum agents. In the past decade, the use of oxaliplatin for the t...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cancer Intelligence
2009
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3224005/ https://ncbi.nlm.nih.gov/pubmed/22276017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2009.153 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|